Treatment guidelines from such major liver societies as the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL) and the Asian Pacific Association for the Study of the Liver (APASL) take into account ALT levels as one of the indicators to start therapy [27–29]. The gene discussed is GPT; the disease is liver disorder.